Internal Server Error

Onkos Surgical - About the company

Onkos Surgical is a series C company based in Parsippany Troy Hills (United States), founded in 2015 by Antony Koblish and Patrick Treacy. It operates as a Modular segmental solutions (3D printing) for orthopedic procedures. Onkos Surgical has raised $110M in funding from Canaan and 1315 Capital. The company has 221 active competitors, including 73 funded and 15 that have exited. Its top competitors include companies like ClearPoint Neuro, LensAR and Proprio.

Company Details

Onkos Surgical is focused on developing implants and instruments for musculoskeletal tumor patients. The Guardian Limb Salvage System is designed to provide options for patients when a surgical intervention is required due to cancer or metastatic diseases. The system is indicated for procedures when a radical resection and replacement of the proximal tibia and/or proximal, distal and/or total femur is required. They use 3D technology to develop modular systems patient specific products. Its solutions include the GUARDIAN Limb Salvage System which includes hinges for the femur and tibia for indications during surgical intervention. It has partnered with Vivex Biomedical to provide a portfolio of tissue products to support the needs of musculoskeletal oncologists. The company's uDesign Patient Solutions is a combination of advanced 3D printing technologies, limb restoration technologies, and biologic solutions.
Social
Facebook
Key Metrics
Founded Year
2015
Location
Parsippany Troy Hills, United States
Stage
Series C
Total Funding
$110M in 6 rounds
Investors
Ranked
Employee Count
104 as on Jul 31, 2026
Similar Companies
Sign up to download Onkos Surgical's company profile

Onkos Surgical's funding and investors

Onkos Surgical has raised a total funding of $110M over 6 rounds. Its first funding round was on Oct 08, 2015. Its latest funding round was a Venture Debt round on Jan 08, 2025 for $*****. 1 investor participated in its latest round. Onkos Surgical has 6 institutional investors.

Here is the list of recent funding rounds of Onkos Surgical:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jan 08, 2025
7463567
Venture Debt
6103934
9469720
7378143
7420217
May 12, 2023
7570805
Series C
1203809
8134207
9949169
Aug 31, 2021
9264348
Series C
9795430
4303071
9629824
8379041
lockAccess funding benchmarks and valuations. Sign up today!

Onkos Surgical's founders and board of directors

Founder? Claim Profile
The founders of Onkos Surgical are Antony Koblish and Patrick Treacy. Patrick Treacy is the CEO of Onkos Surgical.
Here are the details of Onkos Surgical's key team members:

Onkos Surgical's employee count trend

Onkos Surgical has 104 employees as of Jul 26. Here is Onkos Surgical's employee count trend over the years:
Employee count trend for Onkos Surgical
lockUncover Onkos Surgical's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Onkos Surgical's Competitors and alternates

Top competitors of Onkos Surgical include ClearPoint Neuro, LensAR and Proprio. Here is the list of Top 10 competitors of Onkos Surgical, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for ClearPoint Neuro
ClearPoint Neuro
1998, Irvine (United States), Public
Developer of MRI-guided stereotactic system for neurological interventions
$33.7M
64/100
2nd
Logo for LensAR
LensAR
2004, Orlando (United States), Acquired
Laser Technology with AR feature for cataract surgery
$99M
64/100
3rd
Logo for Proprio
Proprio
2016, Seattle (United States), Series B
Manufacturer of surgical navigation platforms using artificial intelligence and sensors
$74.2M
63/100
4th
Logo for Onkos Surgical
Onkos Surgical
2015, Parsippany Troy Hills (United States), Series C
Modular segmental solutions (3D printing) for orthopedic procedures
$110M
63/100
5th
Logo for Apella
Apella
2021, San Francisco (United States), Series B
Developer of surgical systems for the operating room
$101M
63/100
6th
Logo for Hypervision Surgical
Hypervision Surgical
2020, London (United Kingdom), Series A
AI-based tissue analysis software for surgical precision
$31M
60/100
7th
Logo for VitVio
VitVio
2023, San Francisco (United States), Seed
AI and computer vision platform for surgical operating rooms
$10M
59/100
8th
Logo for Caresyntax
Caresyntax
2013, San Francisco (United States), Series C
AI platform that captures and analyzes operating‑room data to optimize surgical workflows and improve patient outcomes
$291M
58/100
9th
Logo for MediView
MediView
2017, Cleveland (United States), Series A
Developer of augmented reality visualization systems for medical surgical procedures
$117M
58/100
10th
Logo for Sim and Cure
Sim and Cure
2014, Montpellier (France), Series A
Designs new generations software to improve neurovascular planning process
$15.3M
55/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Onkos Surgical's competitors? Click here to see the top ones

Onkos Surgical's Investments and acquisitions

Onkos Surgical has made no investments or acquisitions yet.

Reports related to Onkos Surgical

Here is the latest report on Onkos Surgical's sector:

News related to Onkos Surgical

lockFilter this list
Media has covered Onkos Surgical for a total of 3 events in the last 1 year, 3 of them have been about company updates.
•
•
Onkos Surgical Secures $35MOrthopedics•Feb 10, 2025•Onkos Surgical, Horizon
•
FDA clears Onkos Surgical's 3D-printed pelvic reconstruction implantsFierce Biotech•Jul 14, 2022•Onkos Surgical
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Onkos Surgical

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford